• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
391.1437121
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
34.22
83106.9
EPS(TTM)
Face Value()
Div & Yield %
41.81
1
0
 

artemis electicals & projects ltd
Amal consolidated net profit declines 71.98% in the March 2026 quarter
Apr 22,2026
Net profit of Amal declined 71.98% to Rs 1.90 crore in the quarter ended March 2026 as against Rs 6.78 crore during the previous quarter ended March 2025. Sales rose 94.40% to Rs 75.74 crore in the quarter ended March 2026 as against Rs 38.96 crore during the previous quarter ended March 2025.

For the full year,net profit declined 23.59% to Rs 22.38 crore in the year ended March 2026 as against Rs 29.29 crore during the previous year ended March 2025. Sales rose 77.09% to Rs 239.64 crore in the year ended March 2026 as against Rs 135.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales75.7438.96 94 239.64135.32 77
OPM %9.7026.90 -14.8832.00 -
PBDT7.9510.59 -25 37.2641.81 -11
PBT5.608.28 -32 27.9532.61 -14
NP1.906.78 -72 22.3829.29 -24